| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.44B | $1.20B | $637.0M |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | $385.7M | $397.1M | $0 |
| Gross Margin % | 26.7% | 33.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $146.2M | $209.1M | $227.5M |
| Operating Margin % | 10.1% | 17.4% | — |
| Net Income (GAAP) | $107.6M | $168.6M | $177.6M |
| EBITDA (Normalized) | $198.2M | $252.3M | $227.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $534.0K | $192.5M | $158.9M |
| Capital Expenditures (CapEx) | $64.9M | $54.0M | $0 |
| Free Cash Flow (FCF) | -$64.4M | $138.5M | $158.9M |
| FCF Margin % | -4.5% | 11.5% | — |
| Return on Invested Capital (ROIC %) | 9.6% | 19.7% | 8.7% |
| Cash & Short-Term Equivalents | $13.0K | $14.0K | — |
| Total Debt (Short + Long Term) | $394.6M | $275.0M | $799.1M |
| Total Stockholders' Equity | $809.5M | $564.1M | $1.64B |